CLOV vs SARO
Clover Health Investments Corp (CLOV) versus StandardAero, Inc. (SARO) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
StandardAero, Inc. (SARO) is a aerospace & defense company listed on NYSE.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported SARO revenue for 2024-12-31 was $5.24B. Net income was $11.0M. Revenue was up 14.8% from 2023-12-31 to 2024-12-31. SARO currently screens at market cap $9.03B and trailing P/E 30.9.
CLOV currently screens at market cap $1.55B. SARO currently screens at market cap $9.03B and trailing P/E 30.9.
Not investment advice. Open the CLOV and SARO stock pages for the full models.
Not investment advice.